Watchlist

Watchlist
AMAG Pharmaceuticals, Inc. (AMAG)
AMAG Pharmaceuticals, Inc. (AMAG)
Biotech Forum Daily Digest For January 16th
It is amazing how complete is the delusion that beauty is goodness . Leo Tolstoy, The Kreutzer Sonata The market has staged a huge bounce back rally this week after two weeks of brutal declines. After just passing into official 'correction' territory late last week for…
Your Daily Pharma Scoop: Shire Looks Attractive, Omeros Data, Axovant Restructuring
Analysis of top Seeking Alpha coverage: Shire Today we will discuss Shire Plc ( SHPG ), which is continuing with its bad run. Year to date, SHPG shares have fallen nearly 14%. Of course, the sell-off this year can be attributed to the bearish sentiment in general in the market. But Shire al…
Midday Gainers / Losers (2/15/2018)
Gainers: MBRX +61% . AMAG +29% . GLMD +24% . SEDG +20% . LBCC +21% . BBW +17% . COOL +17% . ANDE +16% . WBAI +15% . ATRS +15% . More news on: Moleculin Biotech, Inc., AMAG Pharmaceuticals, Inc., Galmed Pharmaceuticals Ltd., Stocks on the move, , Read mo…
Premarket Gainers as of 9:05 am (02/15/2018)
MBRX +48% on major breakthrough to develop a new cancer treatment. More news on: Moleculin Biotech, Inc., Argos Therapeutics, Inc., AMAG Pharmaceuticals, Inc., Stocks on the move, , Read more …
FDA OKs AMAG Pharma's Makena subcutaneous auto-injector; shares up 16% premarket
AMAG Pharmaceuticals (NASDAQ: AMAG ) is up 16% premarket, albeit on only 100 shares, in response to the FDA's approval of the Makena (hydroxyprogesterone caproate injection) subcutaneous auto-injector, a ready-to-use drug-device combination to reduce the risk of preterm birth…
Biotech Forum Daily Digest For February 12th
T here are some days we can claim and there are other days that claim us . Kamand Kojouri Investors got treated like 'rented mules' this week as the markets suffered their worst weekly loss in some two years. Four of the five trading sessions featured over 1,000 point sw…
Key events next week - healthcare
Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more …
3 Things In Biotech You Should Learn Today: February 6, 2018
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec…
Your Daily Pharma Scoop: AMAG Gets Label Expansion For Feraheme, Bristol-Myers Squibb Reports Results, EyeGate Shares Tumble
Analysis of top Seeking Alpha coverage: AMAG Pharmaceuticals Today we will discuss AMAG Pharmaceuticals ( AMAG ), which as expected got a nod from the FDA for expanded use of Feraheme (ferumoxytol injection) for all eligible adult patients with iron deficiency anemia ( IDA ) who are …
FDA action date today for expanded use of AMAG Pharma's Feraheme; shares up 2%
The FDA's action date (PDUFA) is today for its review of AMAG Pharmaceuticals' ( AMAG +1.5% ) marketing application seeking approval to use Feraheme (ferumoxytol) to treat all adults with iron deficiency anemia (IDA) who are intolerant of or fail to respond adequately to oral iron therapy….
AMAG Pharmaceuticals, Inc. (AMAG)